Associations of granulocyte colony-stimulating factor with toxicities and efficacy of chimeric antigen receptor T-cell therapy in relapsed or refractory B-cell acute lymphoblastic leukemia

Sha Ma, Ying Wang,Kunming Qi, Wenyi Lu,Yuekun Qi, Jiang Cao,Mingshan Niu, Depeng Li,Wei Sang, Zhiling Yan,Feng Zhu, Hai Cheng,Zhenyu Li, Mingfeng Zhao,Kailin Xu

Cancer Immunology, Immunotherapy(2024)

引用 0|浏览2
暂无评分
摘要
Few studies have reported the associations of granulocyte colony-stimulating factor (G-CSF) with cytokine release syndrome (CRS), neurotoxic events (NEs) and efficacy after chimeric antigen receptor (CAR) T-cell therapy for relapsed or refractory (R/R) B-cell acute lymphoblastic leukemia (B-ALL). We present a retrospective study of 67 patients with R/R B-ALL who received anti-CD19 CAR T-cell therapy, 41 (61.2
更多
查看译文
关键词
B-cell acute lymphoblastic leukemia,Chimeric antigen receptor T-cell therapy,Granulocyte colony-stimulating factor,Cytokine release syndrome,Neurotoxic events,Efficacy
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要